MB076
Product Specifications
UNSPSC Description
MB076 is a novel heterocyclic triazole with improved plasma stability. MB076 inhibits seven different Class C Acinetobacter-derived cephalosporinases (ADCs) β-lactamase variants with Ki values [1].
Target Antigen
Antibiotic; Bacterial
Type
ADC Related
Related Pathways
Anti-infection
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/mb076.html
Solubility
10 mM in DMSO
Smiles
NC1=NN=C(SCC(N[C@H](B(O)O)CN2C=C(C(O)=O)N=N2)=O)S1
Molecular Weight
373.18
References & Citations
[1]Rachel A. Powers, et al. Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum. J Med Chem. 2023 Jul 13; 66(13): 8510–8525.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-155011/MB076-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-155011/
Clinical Information
No Development Reported
CAS Number
2832966-95-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6403858-01 0.1 mL
CSF1 (Macrophage Colony-stimulating Factor 1, CSF-1, M-CSF, MCSF, Lanimostim, MGC31930) (MaxLight 490)
Ask
View Details